Sign inJoin waitlistJoin the waitlist

Paula Klein

Hematology & Oncology · Icahn School of Medicine at Mount Sinai

Credentials: · · ·

History

Research

Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative…
Journal of Clinical Oncology · 2018 · 158 citations
Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer
JAMA · 2017 · 128 citations
An emerging generation of endocrine therapies in breast cancer: a clinical perspective
Review · npj Breast Cancer · 2023 · 125 citations

Theresa Shao
7 papers
Amy Tiersten
5 papers
Joseph Sparano
5 papers
Anupama Goel
4 papers
FM
Franco Muggia
4 papers
Julie Fasano
4 papers
Rima Patel
4 papers · 4 as a fellow
AB
Aarti Bhardwaj
3 papers
CS
Charles Shapiro
3 papers
Susan Boolbol
3 papers
Alaina Kessler
2 papers
AW
Antonio Wolff
2 papers

Clinical trials

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2023–2032